Jrsis Health Care Corp (JRSS) Return on Investment ROI from the third quarter of 2024 to third quarter of 2023 and for the year 2024, average high and low, overall ranking from Sep 30 2024 to Sep 30 2023 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Jrsis Health Care Corp  (JRSS)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Jrsis Health Care's ROI from its third quarter of 2024 to the third quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Jrsis Health Care's ROI in the third quarter of 2024?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Jrsis Health Care Corp's return on investment (ROI) in its third quarter of 2024

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter
Y / Y Investment Change TTM - - -76.34 % -97.83 % -98.47 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 0 0 0 0 0
Return On Investment (TTM) - - - - -92 %
JRSS's Overall Ranking # # # # #
Seq. Investment Change TTM - - -63.56 % -4.34 % -18.84 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 0 0 0 0 0

JRSS Company Profile >> Back to JRSS Roi Comparisons >> See Annual JRSS Return On Investment



Return On Investment JRSS's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Jrsis Health Care's III. Quarter Investments $ 0 Millions JRSS's Balance sheet
Jrsis Health Care's III. Quarter Income $ 0 Millions Quarterly JRSS's Income Statement
JRSS's Income by Division See JRSS's Income by Division


JRSS Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
Total Investments in Millions 0 1 69 57 49
Y / Y Investment Growth - -98.82 % 21.59 % 16.3 % -8.1 %
Net Income in Millions 0 -34 3 4 1
Y / Y Net Income Growth - - -16.68 % 201.68 % -55.44 %
Annual Return On Investment - -4148.9 % 4.61 % 6.73 % 2.6 %


Annual Roi Comment
In the fiscal year 2023 ROI improved to 2.6 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
JRSS's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for JRSS's Competitors
Subscribers only: Roi for Jrsis Health Care's Suppliers
Subscribers only: Return On Investment for JRSS's Customers

Other Ratios
JRSS's Roa JRSS's Inventory Turnover Ratio JRSS's Growth Rates JRSS's Dividend Statistics
JRSS's Profitability Ratios JRSS's Asset Turnover Ratio JRSS's Dividend Growth
JRSS's Roe JRSS's Valuation Ratios JRSS's Financial Strength Ratios JRSS's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2024, within Healthcare Sector ROI
Longduoduo Co Ltd  193.93 %
Camp4 Therapeutics Corporation  109.71 %
Gridai Technologies Corp  89.12 %
Earth Science Tech Inc   80.56 %
Oak Woods Acquisition Corp  79.63 %
Roivant Sciences Ltd   67.12 %
Agios Pharmaceuticals Inc   66.60 %
Keenova Therapeutics Plc  59.53 %
Pavmed Inc   57.26 %
Valion Bio Inc   55.77 %
Entera Bio Ltd   55.46 %
Mimedx Group Inc   53.81 %
Siga Technologies Inc  48.09 %
Dariohealth Corp   47.56 %
Edwards Lifesciences Corporation  45.32 %
Cytomx Therapeutics Inc   45.29 %
Exelixis Inc   42.79 %
Mettler toledo International Inc   37.76 %
Idexx Laboratories Inc  36.53 %
Medpace Holdings Inc   35.86 %
Tg Therapeutics Inc   34.74 %
Protagonist Therapeutics inc   33.20 %
Pharmacyte Biotech Inc   32.94 %
Entrada Therapeutics Inc   32.63 %
Nrc Health  32.53 %
Lantheus Holdings Inc   28.51 %

Date modified: 2026-08-29T17:25:28+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.